MDM4 was associated with poor prognosis and tumor-immune infiltration of cancers
Abstract MDM4 is one of the MDM protein family and is generally recognized as the key negative regulator of p53. As a cancer-promoting factor, it plays a non-negligible role in tumorigenesis and development. In this article, we analyzed the expression levels of MDM4 in pan-cancer through multiple da...
Main Authors: | Jie Liu, Jie Yang, Qilong Pan, Xiangyu Wang, Xinyin Wang, Han Chen, Xiaoling Zheng, Qingling Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | European Journal of Medical Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40001-024-01684-z |
Similar Items
-
NMI: a potential biomarker for tumor prognosis and immunotherapy
by: Teng He, et al.
Published: (2022-11-01) -
SCNN1A Overexpression Correlates with Poor Prognosis and Immune Infiltrates in Ovarian Cancer
by: Lou J, et al.
Published: (2022-02-01) -
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
by: Johanna Huun, et al.
Published: (2017-04-01) -
ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysis
by: Yijie Ning, et al.
Published: (2023-01-01) -
Pan-cancer analysis reveals the relationship between RCSD1 immune infiltration and clinical prognosis in human tumors
by: Han Qiao, et al.
Published: (2022-10-01)